ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
-0,58%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,185
-1,27%
Bitcoin
61 922,43
2,75%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Black Diamond Therapeutics Inc (BDTX)

  7. Black Diamond Therapeutics Inc (BDTX) Actualités

BDTX Black Diamond Therapeutics Inc

4,65
-0,23 (-4,71%)
Après les heures de négociation
Dernière mise à jour : 23:33:28
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Black Diamond Therapeutics Inc BDTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,23 -4,71% 4,65 23:33:28
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,88 4,57 4,95 4,69 4,88
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/6/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 8-K - Current report
01/6/202416:00GLOBEBlack Diamond Therapeutics Presents Promising BDTX-1535..
29/5/202414:00GLOBEBlack Diamond Therapeutics to Participate in Jefferies..
14/5/202401:09EDGAR2Form SC 13D/A - General statement of acquisition of..
09/5/202413:30GLOBEBlack Diamond Therapeutics Reports First Quarter 2024..
09/5/202413:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:10EDGAR2Form 8-K - Current report
24/4/202422:05GLOBEBlack Diamond Therapeutics Announces Presentations at the..
11/4/202414:00GLOBEBlack Diamond Therapeutics Announces Changes to Board of..
08/4/202400:00GLOBEBlack Diamond Therapeutics Presents Novel Real-World..
03/4/202414:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
12/3/202413:00GLOBEBlack Diamond Therapeutics Reports Fourth Quarter and Full..
11/3/202418:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/3/202422:30GLOBEBlack Diamond Therapeutics Announces Upcoming Presentation..
28/2/202414:00GLOBEBlack Diamond Therapeutics to Participate in the TD Cowen..
15/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:04EDGAR2Form 8-K - Current report
04/1/202414:07EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEBlack Diamond Therapeutics Announces Corporate Update and..
13/12/202313:08EDGAR2Form 8-K - Current report
13/12/202313:00GLOBEBlack Diamond Therapeutics Announces Topline Results from..
07/11/202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
06/11/202313:45GLOBEBlack Diamond Therapeutics Reports Third Quarter 2023..
06/11/202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:10EDGAR2Form 8-K - Current report
14/10/202318:30GLOBEBlack Diamond Therapeutics Presents Dose Escalation Data..
04/10/202318:14GLOBEBlack Diamond Therapeutics to Present Preclinical and..
18/9/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202313:12EDGAR2Form 8-K - Current report
18/9/202313:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
11/9/202314:00GLOBEBlack Diamond Therapeutics Announces First Patients Dosed in..
05/9/202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
11/8/202313:30GLOBEBlack Diamond Therapeutics Reports Second Quarter 2023..
11/8/202313:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202313:22EDGAR2Form 8-K - Current report
30/6/202322:03EDGAR2Form 8-K - Current report
30/6/202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/6/202302:57GLOBEBlack Diamond Therapeutics Announces Pricing of Public..
29/6/202312:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202322:23GLOBEBlack Diamond Therapeutics Announces Proposed Public..
27/6/202313:00GLOBEBlack Diamond Therapeutics Announces Initial Dose Escalation..

Dernières Valeurs Consultées

NASDAQ
BDTX
Black Diamond Therapeutics
TSXV
CUB.DB
CubicFarm Systems
NASDAQ
SVVC
Firsthand Technology Value
TSXV
DSP
USOTC
DGNG
Diguang International De... (PK)
LSE
FH48
Chna Con Ln 25
UNSW3
PIPETH
PIP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés